Dr. Tatum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1145 S Utica Ave
Suite 701
Tulsa, OK 74104Phone+1 918-582-6544Fax+1 918-582-6549
Education & Training
- University of Nebraska Medical Center College of MedicineFellowship, Gastroenterology, 1983 - 1985
- University of Oklahoma School of Community Medicine (Tulsa)Residency, Internal Medicine, 1980 - 1983
- University of Oklahoma College of MedicineClass of 1980
Certifications & Licensure
- OK State Medical License 1981 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Oklahoma Magazine Castle Connolly, 2008-2013
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012
- Fellow (FACP) American College of Physicians, 1998
- Join now to see all
Clinical Trials
- Longitudinal Assessment of Cardiovascular and Renal Health in Patients With Hepatitis-C (CARE-Hep C) Start of enrollment: 2013 May 10
- Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for Testing Start of enrollment: 2014 Feb 01
Publications & Presentations
PubMed
- 11 citationsA randomized, placebo-controlled study of the NS5B inhibitor beclabuvir with peginterferon/ribavirin for HCV genotype 1.Harvey A Tatum, Paul J. Thuluvath, Eric Lawitz, Claudia Martorell, M. Demicco
Journal of Viral Hepatitis. 2015-08-01 - 43 citationsDaclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infectionGregory J. Dore, Eric Lawitz, Christophe Hézode, Stephen D. Shafran, Alnoor Ramji
Gastroenterology. 2015-02-01 - 123 citationsDaclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a t...Stanislas Pol, Reem Ghalib, Vinod K. Rustgi, Claudia Martorell, G.T. Everson
The Lancet. Infectious Diseases. 2012-09-01
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: